Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Current Assets: 2009-2025

Historic Current Assets for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to $85.7 million.

  • Lifecore Biomedical's Current Assets rose 5.73% to $85.7 million in Q2 2025 from the same period last year, while for May 2025 it was $85.7 million, marking a year-over-year increase of 5.73%. This contributed to the annual value of $85.7 million for FY2025, which is 5.73% up from last year.
  • Lifecore Biomedical's Current Assets amounted to $85.7 million in FY2025, which was up 5.73% from $81.0 million recorded in FY2024.
  • Lifecore Biomedical's 5-year Current Assets high stood at $145.3 million for FY2021, and its period low was $81.0 million during FY2024.
  • Over the past 3 years, Lifecore Biomedical's median Current Assets value was $85.7 million (recorded in 2025), while the average stood at $86.9 million.
  • Per our database at Business Quant, Lifecore Biomedical's Current Assets declined by 19.71% in 2022 and then rose by 5.73% in 2025.
  • Over the past 5 years, Lifecore Biomedical's Current Assets (Yearly) stood at $145.3 million in 2021, then fell by 19.71% to $116.7 million in 2022, then decreased by 19.54% to $93.9 million in 2023, then dropped by 13.68% to $81.0 million in 2024, then climbed by 5.73% to $85.7 million in 2025.